Screener
Vertex Pharmaceuticals VRTX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's prepaid & other current?
- Vertex Pharmaceuticals (VRTX) reported prepaid & other current of $791.9M in Q2 2026.
- How has Vertex Pharmaceuticals's prepaid & other current changed year-over-year?
- Vertex Pharmaceuticals's prepaid & other current increased by 21.4% year-over-year, from $652.3M to $791.9M.
- What is the long-term trend for Vertex Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's prepaid & other current has grown at a 22.6% compound annual growth rate (CAGR), from $308.3M to $853.3M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Vertex Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude